FDA clears device that treats diabetic foot ulcers for market

The FDA announced today that it has cleared the Dermapace System diabetic foot ulcer treatment device for market. Dermapace System is the first shockwave device to treat foot ulcers caused by diabetes, according to the device’s creator Sanuwave. “Diabetes is the leading cause of lower limb amputations,” Binita Ashar, director of the division of surgical

Medtech stories we missed this week: Aug. 18, 2017

From Nemaura’s new Oceania distribution deal to Sanuwave’s promissory note expansion, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Nemaura inks Oceania distribution deal for SugarBeat patch Nemaura announced in an Aug. 15 press release that it has signed a non-binding distribution deal with Device Technologies for